FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386157169> ?p ?o ?g. }

• W4386157169 endingPage "95" @default.
• W4386157169 startingPage "91" @default.
• W4386157169 abstract "Background: Tuberculosis (TB) continues to be a significant public health issue despite extensive efforts to control it. The standard treatment for TB involves the use of first-line anti-TB drugs administered at a standard dose. However, the effectiveness of this treatment can vary between individual patients, resulting in differing cure rates.&#x0D; Methodology: The objective of this retrospective study was to assess the effectiveness and safety of first-line generic anti-TB medications administered at Liwa Hospital in the Al Dhafra Region. Data was collected from the electronic medical records of 140 TB patients admitted to Liwa Hospital from January to December 2022. The study included patients with positive acid-fast bacillus (AFB) or polymerase chain reaction (PCR) test results, indicating active TB infection. Patients resistant to first-line anti-TB medications or with lung cancer were excluded. Data collected included demographic information, length of stay conversion time, hospital admission, prescribed medications, treatment duration, and treatment outcomes.&#x0D; Results: This study observed an average length of stay of 21 days for patients treated with first-line generic anti-TB medications at Liwa Hospital. Over 80% of the patients were discharged within 30 days of admission, indicating a positive response to the medications. Approximately 13% of the patients required a longer duration of treatment and were discharged between 30 and 60 days after admission. Only 5% of the patients had a prolonged stay of over 60 days, most of whom had co-morbidities or rifampicin resistance, but achieved AFB conversion within three months. The average conversion time for patients was 25 days, with over 92% achieving conversion within two months.&#x0D; Conclusion: This study demonstrated the efficacy and safety of first-line generic anti-TB medications in treating TB patients at Liwa Hospital. The majority of patients responded well to the medications, leading to discharge within 30 days.&#x0D; Keywords: Tuberculosis, Ethambutol, Pyrazinamide, Rifampicin, Isoniazid, First line drugs, Anti TB drugs" @default.
• W4386157169 created "2023-08-26" @default.
• W4386157169 creator A5079698723 @default.
• W4386157169 creator A5085705511 @default.
• W4386157169 creator A5092693420 @default.
• W4386157169 date "2023-08-15" @default.
• W4386157169 modified "2023-09-25" @default.
• W4386157169 title "Evaluating the effectiveness of first-Line anti-tuberculosis in Al Dhafra Hospitals" @default.
• W4386157169 doi "https://doi.org/10.22270/jddt.v13i8.5939" @default.
• W4386157169 hasPublicationYear "2023" @default.
• W4386157169 type Work @default.
• W4386157169 citedByCount "0" @default.
• W4386157169 crossrefType "journal-article" @default.
• W4386157169 hasAuthorship W4386157169A5079698723 @default.
• W4386157169 hasAuthorship W4386157169A5085705511 @default.
• W4386157169 hasAuthorship W4386157169A5092693420 @default.
• W4386157169 hasBestOaLocation W43861571691 @default.
• W4386157169 hasConcept C126322002 @default.
• W4386157169 hasConcept C142724271 @default.
• W4386157169 hasConcept C167135981 @default.
• W4386157169 hasConcept C187212893 @default.
• W4386157169 hasConcept C194828623 @default.
• W4386157169 hasConcept C195910791 @default.
• W4386157169 hasConcept C2778607973 @default.
• W4386157169 hasConcept C2781069245 @default.
• W4386157169 hasConcept C2993493390 @default.
• W4386157169 hasConcept C71924100 @default.
• W4386157169 hasConceptScore W4386157169C126322002 @default.
• W4386157169 hasConceptScore W4386157169C142724271 @default.
• W4386157169 hasConceptScore W4386157169C167135981 @default.
• W4386157169 hasConceptScore W4386157169C187212893 @default.
• W4386157169 hasConceptScore W4386157169C194828623 @default.
• W4386157169 hasConceptScore W4386157169C195910791 @default.
• W4386157169 hasConceptScore W4386157169C2778607973 @default.
• W4386157169 hasConceptScore W4386157169C2781069245 @default.
• W4386157169 hasConceptScore W4386157169C2993493390 @default.
• W4386157169 hasConceptScore W4386157169C71924100 @default.
• W4386157169 hasIssue "8" @default.
• W4386157169 hasLocation W43861571691 @default.
• W4386157169 hasOpenAccess W4386157169 @default.
• W4386157169 hasPrimaryLocation W43861571691 @default.
• W4386157169 hasRelatedWork W2139352390 @default.
• W4386157169 hasRelatedWork W2477714387 @default.
• W4386157169 hasRelatedWork W3048921073 @default.
• W4386157169 hasRelatedWork W3141613231 @default.
• W4386157169 hasRelatedWork W3195196921 @default.
• W4386157169 hasRelatedWork W3195384805 @default.
• W4386157169 hasRelatedWork W4221019750 @default.
• W4386157169 hasRelatedWork W4283591600 @default.
• W4386157169 hasRelatedWork W4310168951 @default.
• W4386157169 hasRelatedWork W4383906465 @default.
• W4386157169 hasVolume "13" @default.
• W4386157169 isParatext "false" @default.
• W4386157169 isRetracted "false" @default.
• W4386157169 workType "article" @default.